David Hernandez

David Hernandez has a diverse work experience in the pharmaceutical industry. David started their career at Barr Laboratories and Teva Pharmaceuticals as a Regulatory Compliance Associate before moving to Nycomed as a Regulatory Affairs Associate. David then joined Actavis plc (now Allergan) as a Regulatory Affairs Associate III. David later joined Alvogen, where they held roles as Manager and Associate Director of Regulatory Affairs. In 2015, they joined Chemo as a Regulatory Affairs professional. Currently, they are working at Xiromed, LLC, where they have held various positions including Vice President of Regulatory Affairs and Quality Operations, Vice President of Regulatory Affairs, and Vice President of Regulatory Strategy, Portfolio, and Business Development. Their expertise lies in regulatory strategy, portfolio management, and US R&D operations.

David Hernandez pursued their education at various institutions, starting with their Bachelor's of Science degree in Biology with a concentration in Molecular Biology from Purchase College, SUNY. David attended this school from 2005 to 2007. Later, in 2008 to 2009, they pursued a Master's of Science degree in Regulatory Affairs at Northeastern University. Lastly, in 2016 to 2017, David engaged in executive development at the IESE Business School where they focused on expanding their skills and knowledge in a specific area.